Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
825 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00457392 | A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone | completed | Phase 3 | 960 | PfizerINDUSTRY | 26 | Oct 29, 2013 | clinicaltrials |
| NCT00147550 | MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma. | terminated | Phase 1 / Phase 2 | 79 | PfizerINDUSTRY | 1 | Sep 13, 2013 | clinicaltrials |
| Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer(NSCLC) |
| terminated |
| Phase 3 |
| 583 |
| PfizerINDUSTRY |
| 27 |
| Jul 24, 2013 |
| clinicaltrials |
| NCT01073644 | Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino Patients | terminated | — | 3 | PfizerINDUSTRY | 1 | Jul 4, 2013 | clinicaltrials |
| NCT01459757 | Non-Interventional Retrospective Correlation Of Tumor Mutational Status To Clinical Benefit Of GIST Patients Treated With Sunitinib | completed | — | 322 | PfizerINDUSTRY | 16 | Jun 19, 2013 | clinicaltrials |
| NCT00662025 | Study Of Sunitinib With Capecitabine In Breast Cancer | completed | Phase 2 | 63 | PfizerINDUSTRY | 1 | May 27, 2013 | clinicaltrials |
| NCT00443534 | A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol. | completed | N/A | 123 | PfizerINDUSTRY | 7 | May 24, 2013 | clinicaltrials |
| NCT00560560 | Study Using CP-751,871 In Patients With Stage IV Colorectal Cancer That Has Not Responded To Previous Anti-Cancer Treatments | completed | Phase 2 | 168 | PfizerINDUSTRY | 3 | May 20, 2013 | clinicaltrials |
| NCT01781442 | A Post Marketing Surveillance As Required By Philippine Food And Drug Administration | withdrawn | — | 0 | PfizerINDUSTRY | 0 | May 1, 2013 | clinicaltrials |
| NCT00313781 | Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC) | completed | Phase 2 | 204 | PfizerINDUSTRY | 6 | Apr 11, 2013 | clinicaltrials |
| NCT00603538 | Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer | completed | Phase 1 | 19 | PfizerINDUSTRY | 1 | Apr 11, 2013 | clinicaltrials |
| NCT00494091 | Study Evaluating The Safety, Efficacy & Pharmacokinetics Of Temsirolimus(CCI-779) In Subjects With Advanced Renal Cell Carcinoma | completed | Phase 2 | 82 | PfizerINDUSTRY | 3 | Mar 21, 2013 | clinicaltrials |
| NCT00560573 | Study Of CP-751,871 In Combination With Cisplatin And Gemcitabine In Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 1 | 46 | PfizerINDUSTRY | 3 | Mar 21, 2013 | clinicaltrials |
| NCT01105533 | A Dose Finding Study Of A New Medication, PF-00337210 That Will Possibly Decrease Blood Supply To Tumors | completed | Phase 1 | 46 | PfizerINDUSTRY | 1 | Mar 19, 2013 | clinicaltrials |
| NCT01536145 | CP-751,871 Treatment For Patients With Multiple Myeloma | completed | Phase 1 | 47 | PfizerINDUSTRY | 1 | Mar 15, 2013 | clinicaltrials |
| NCT00676650 | Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy(SUN 1120) | terminated | Phase 3 | 873 | PfizerINDUSTRY | 22 | Mar 8, 2013 | clinicaltrials |
| NCT00977561 | A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer | terminated | Phase 2 | 9 | PfizerINDUSTRY | 4 | Feb 25, 2013 | clinicaltrials |
| NCT00959946 | Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 32 | PfizerINDUSTRY | 6 | Feb 22, 2013 | clinicaltrials |
| NCT00037596 | Study Evaluating Gemtuzumab Ozogamicin in Acute Myeloid Leukemia | completed | Phase 2 | — | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 0 | Feb 13, 2013 | clinicaltrials |
| NCT00195260 | Study Evaluating SKI-606 (Bosutinib) In Advanced Malignant Solid Tumors | completed | Phase 1 | 151 | PfizerINDUSTRY | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00106353 | Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors | completed | Phase 1 / Phase 2 | 71 | PfizerINDUSTRY | 7 | Feb 8, 2013 | clinicaltrials |
| NCT00265317 | A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone(SUN1058) | completed | Phase 2 | 162 | PfizerINDUSTRY | 8 | Feb 6, 2013 | clinicaltrials |
| NCT00319254 | Study Evaluating SKI-606 (Bosutinib) In Subjects With Breast Cancer | completed | Phase 2 | 75 | PfizerINDUSTRY | 8 | Jan 31, 2013 | clinicaltrials |
| NCT00798889 | Rollover Protocol for Prior SU011248 Protocols | completed | N/A | 314 | PfizerINDUSTRY | 11 | Jan 21, 2013 | clinicaltrials |
| NCT00706706 | Safety And Efficacy Study Of Sunitinib Malate As First-Line Systemic Therapy In Chinese Patients With Metastatic Renal Cell Carcinoma(MRCC RCC) | completed | Phase 4 | 105 | PfizerINDUSTRY | 1 | Jan 18, 2013 | clinicaltrials |
| NCT00555620 | Study Of Sunitinib In Combination With Cisplatin/Capecitabine Or Oxaliplatin/Capecitabine In Patients With Advanced Gastric Cancer | completed | Phase 1 | 76 | PfizerINDUSTRY | 1 | Jan 14, 2013 | clinicaltrials |
| NCT00699374 | Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer | terminated | Phase 3 | 1,075 | PfizerINDUSTRY | 23 | Jan 14, 2013 | clinicaltrials |
| NCT00735904 | Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer | completed | Phase 2 | 38 | PfizerINDUSTRY | 4 | Jan 3, 2013 | clinicaltrials |
| NCT00372424 | Study Of SU011248 In Combination With Docetaxel And Trastuzumab In Patients With Advanced Breast Cancer HER-2 Positive | completed | Phase 1 | 26 | PfizerINDUSTRY | 2 | Dec 28, 2012 | clinicaltrials |
| NCT01603264 | A Pharmacokinetic Study Comparing PF-05280014 And Trastuzumab In Healthy Male Volunteers (REFLECTIONS B327-01) | completed | Phase 1 | 105 | PfizerINDUSTRY | 1 | Dec 18, 2012 | clinicaltrials |
| NCT01602887 | Relative Bioavailability Study | completed | Phase 1 | 24 | PfizerINDUSTRY | 1 | Nov 12, 2012 | clinicaltrials |
| NCT00873210 | Study In Patients With Kidney Cancer Treated With Sutent | completed | — | 121 | PfizerINDUSTRY | 1 | Nov 9, 2012 | clinicaltrials |
| NCT00793546 | Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer | terminated | Phase 2 | 42 | PfizerINDUSTRY | 11 | Nov 5, 2012 | clinicaltrials |
| NCT01239745 | Aromasin® As Adjuvant Treatment In Postmenopausal Women With Invasive, Estrogen Receptor Positive Early Breast Cancer | terminated | — | 46 | PfizerINDUSTRY | 3 | Oct 31, 2012 | clinicaltrials |
| NCT01658176 | Study Of PF-04691502 (PI3K/mTOR Inhibitor) In Combination With Exemestane Compared With Exemestane Alone In Patients With Advanced Breast Cancer | withdrawn | Phase 2 | 0 | PfizerINDUSTRY | 0 | Oct 29, 2012 | clinicaltrials |
| NCT00065468 | Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma(ARCC) | completed | Phase 3 | 626 | PfizerINDUSTRY | 25 | Oct 25, 2012 | clinicaltrials |
| NCT00609622 | Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer | terminated | Phase 2 | 191 | PfizerINDUSTRY | 4 | Oct 11, 2012 | clinicaltrials |
| NCT01155063 | Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients | terminated | — | 89 | PfizerINDUSTRY | 0 | Oct 1, 2012 | clinicaltrials |
| NCT00003775 | Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse | completed | Phase 2 | 60 | PfizerINDUSTRY | 2 | Sep 13, 2012 | clinicaltrials |
| NCT00003293 | SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme | completed | Phase 3 | — | PfizerINDUSTRY | 2 | Sep 11, 2012 | clinicaltrials |
| NCT00004071 | Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer | completed | Phase 2 / Phase 3 | — | PfizerINDUSTRY | 1 | Sep 11, 2012 | clinicaltrials |
| NCT00004252 | Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 3 | — | PfizerINDUSTRY | 1 | Sep 11, 2012 | clinicaltrials |
| NCT00373256 | A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer | completed | Phase 3 | 488 | PfizerINDUSTRY | 4 | Sep 10, 2012 | clinicaltrials |
| NCT00338884 | Safety And Effectiveness Of Daily Dosing With 37.5 mg Sunitinib Malate In Patients With Advanced Kidney Cancer | completed | Phase 2 | 120 | PfizerINDUSTRY | 6 | Aug 31, 2012 | clinicaltrials |
| NCT00003720 | SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma | completed | Phase 1 | — | PfizerINDUSTRY | 1 | Aug 23, 2012 | clinicaltrials |
| NCT00003131 | CMA-676 in Treating Patients With Acute Myeloid Leukemia in First Relapse | completed | Phase 2 | 55 | PfizerINDUSTRY | 1 | Aug 22, 2012 | clinicaltrials |
| NCT00003673 | CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse | completed | Phase 2 | 55 | PfizerINDUSTRY | 1 | Aug 22, 2012 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials